| |
| |
|
| Insider
Information: |
Freedman Lori |
| Relationship: |
Chief Admin. and Legal... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
565,695 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,464,561 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
565,695 |
|
|
| Total
Value |
$1,464,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
EyePoint Pharmaceuticals Inc |
EYPT |
VP Corp. Affairs, GC a... |
2014-06-17 |
96,423 |
|
0 |
Premium* |
|
|
Organogenesis Holdings Inc |
ORGO |
Chief Admin. and Legal... |
2024-04-01 |
469,272 |
2020-04-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ORGO |
Organogenesis Holdings In... |
Chief Admin. and Legal Officer |
• – – |
2024-04-01 |
4 |
D |
$2.80 |
$5,527 |
D/D |
(1,974) |
469,272 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
Chief Admin. and Legal Officer |
• – – |
2024-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
153,061 |
471,246 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
Chief Admin. and Legal Officer |
• – – |
2024-02-16 |
4 |
D |
$3.48 |
$2,248 |
D/D |
(646) |
318,185 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
Chief Admin. and Legal Officer |
• – – |
2024-02-15 |
4 |
D |
$3.68 |
$92,585 |
D/D |
(25,159) |
318,831 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
VP and General Counsel |
• – – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
278,884 |
346,329 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
VP and General Counsel |
• – – |
2023-02-16 |
4 |
D |
$2.75 |
$2,104 |
D/D |
(765) |
67,445 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
VP and General Counsel |
• – – |
2023-02-15 |
4 |
D |
$2.92 |
$10,614 |
D/D |
(3,635) |
68,210 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
VP and General Counsel |
• – – |
2022-04-01 |
4 |
D |
$7.89 |
$23,544 |
D/D |
(2,984) |
71,845 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
VP and General Counsel |
• – – |
2022-02-16 |
4 |
D |
$7.78 |
$5,952 |
D/D |
(765) |
74,829 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
VP and General Counsel |
• – – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
41,843 |
75,594 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
VP and General Counsel |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,808 |
35,726 |
0 |
- |
|
| ORGO |
Organogenesis Holdings In... |
VP and General Counsel |
• – – |
2020-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
26,918 |
26,918 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-17 |
4 |
AS |
$4.00 |
$17,856 |
D/D |
(4,464) |
96,423 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-17 |
4 |
OE |
$1.81 |
$8,080 |
D/D |
4,464 |
100,887 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-16 |
4 |
AS |
$4.01 |
$13,778 |
D/D |
(3,436) |
96,423 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-16 |
4 |
OE |
$1.81 |
$6,219 |
D/D |
3,436 |
99,859 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-13 |
4 |
AS |
$4.01 |
$8,421 |
D/D |
(2,100) |
96,423 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-13 |
4 |
OE |
$1.81 |
$3,801 |
D/D |
2,100 |
98,523 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-12 |
4 |
OE |
$1.81 |
$17,376 |
D/D |
9,600 |
106,023 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-06-12 |
4 |
AS |
$4.02 |
$38,592 |
D/D |
(9,600) |
96,423 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-05-05 |
4 |
AS |
$4.01 |
$14,035 |
D/D |
(3,500) |
96,423 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp. Affairs, GC and Sec |
• – – |
2014-05-05 |
4 |
OE |
$1.81 |
$6,335 |
D/D |
3,500 |
99,923 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp Affairs,Gen Coun & Sec |
• – – |
2009-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
31,616 |
96,423 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp Affairs,Gen Coun & Sec |
• – – |
2008-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,807 |
|
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
VP Corp Affairs,Gen Coun & Sec |
• – – |
2007-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,592,320 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
